Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer

Mok T.S.K.Wu Y.-L.CHONG-JEN YUZhou C.Chen Y.-M.Zhang L.Ignacio J.Liao M.Srimuninnimit V.Boyer M.J.Chua-Tan M.Sriuranpong V.Sudoyo A.W.Jin K.Johnston M.Chui W.Lee J.-S.2022-06-272022-06-2720090732-183Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-75249084998&doi=10.1200%2fJCO.2008.21.5541&partnerID=40&md5=c277a8fdd674a2fea8729e814c18f34ehttps://scholars.lib.ntu.edu.tw/handle/123456789/614479[SDGs]SDG3Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancerjournal article10.1200/JCO.2008.21.5541197381252-s2.0-75249084998